Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19.

Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19. Am J Respir Crit Care Med. 2020 Sep 08;: Authors: Zelek WM, Cole J, Ponsford MJ, Harrison RA, Schroeder BE, Webb N, Jolles S, Fegan C, Morgan M, Wise MP, Morgan BP PMID: 32897730 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32897730?dopt=Abstract

Source: American Journal of Respiratory and Critical Care Medicine - September 7, 2020 Category: Respiratory Medicine Authors: Zelek WM, Cole J, Ponsford MJ, Harrison RA, Schroeder BE, Webb N, Jolles S, Fegan C, Morgan M, Wise MP, Morgan BP Tags: Am J Respir Crit Care Med Source Type: research

More News: COVID-19 | Respiratory Medicine